About

Twist Bioscience specializes in the synthesis of synthetic DNA, which is essential for various applications in biotechnology, pharmaceuticals, and research. Their proprietary platform enables the rapid and accurate production of DNA sequences, allowing clients such as academic institutions and pharmaceutical companies to develop new drugs, diagnose diseases, and conduct genetic research. Twist Bioscience differentiates itself from competitors by offering high-quality DNA sequences at competitive prices and the ability to handle complex DNA sequences. Their product range includes genes, oligo pools, variant libraries, and tools for SARS-CoV-2, along with DNA data storage and next-generation sequencing services. The company's goal is to be a leading supplier in the synthetic biology and genomics sector, providing valuable resources to the scientific community.

Simplify's Take

What believers are saying

• Collaboration with Absci positions Twist at the forefront of AI-driven drug development.
• Launch of Transaminase Enzyme Screening Kit opens growth in industrial biotechnology.
• Expansion of IgG antibody portfolio strengthens position in therapeutic antibody market.

What critics are saying

• Increased competition from companies like Ginkgo Bioworks could capture market share.
• Potential ethical and regulatory challenges associated with synthetic DNA scrutiny.
• Rapid technological advancements could lead to obsolescence of current platforms.

What makes Twist Bioscience unique

• Twist Bioscience uses a unique silicon-based DNA synthesis platform for precision and scale.
• They offer high-quality DNA sequences at competitive prices, attracting diverse clients.
• Their proprietary platform provides instant feedback on DNA sequence synthesis feasibility.

Help us improve and share your feedback! Did you find this helpful?

YesNo